A new study reports one of the biggest potential advances against heart failure in more than a decade -- a first-of-a-kind, experimental drug that lowered the chances of death or hospitalization by about 20 percent.
Associated Press, The Post-Standard
Sat, 08/30/2014 - 10:01am
A new study reports one of the biggest potential advances against heart failure in more than a decade -- a first-of-a-kind, experimental drug that lowered the chances of death or hospitalization by about 20 percent.